Assertio Holdings ISIN: US04546C2052 Forum: Aktien User: Summer.76

https://finance.yahoo.com/news/assertio-holdings-joins-russell-3000-110000866.html

https://www.globenewswire.com/news-release/2023/08/03/2718527/0/en/Assertio-Reports-Second-Quarter-2023-Financial-Results-Closes-Spectrum-Acquisition.html

Bin nun auch unfreiwillig hier.... Ob das nun gut ist weiß ich noch nicht....

Jou, sollte jetzt eigentlich nur noch eine Richtung kennen.. Deren Zahlen sind jedenfalls Bombe.

Hab nach der Übernahme wohl erstmal die Hälfte verloren....

https://finance.yahoo.com/news/assertio-holdings-inc-acquire-spectrum-100000644.html

Did you see the fusion with **** pharma?

https://finance.yahoo.com/news/assertio-provides-educational-grant-lennox-130000477.html

🍀

ASSERTIO REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS https://investor.assertiotx.com/news/news-details/2023/Assertio-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results/default.aspx Net Product Sales Increase 55% in the Fourth Quarter, 42% for the Full Year Full Year Net Income Increases to $109.6 Million, Non-GAAP Adjusted EBITDA Increases to $101.6 Million Cash Flows from Operations Was $26.7 Million for the Fourth Quarter and $78.6 Million for the Full Year

Assertio Holdings: Compelling Income Opportunity Apart From Upside Potential https://seekingalpha.com/article/4581797-assertio-holdings-compelling-income-opportunity-apart-from-upside-potential Summary • Q4 preliminary results illustrate the best product sales quarter for the past 5 years. • Technicals, valuation, and profitability trends all point to rising prices for the stock. • An aggressive covered call strategy is an excellent play here for both income and capital appreciation purposes. ...

Assertio Announces Exchange Offer of $30 Million of its Currently Outstanding 6.50% Convertible Senior Notes Due 2027 https://finance.yahoo.com/news/assertio-announces-exchange-offer-30-121400733.html

https://finance.yahoo.com/news/assertio-holdings-inc-announces-preliminary-120000679.html

https://seekingalpha.com/article/4571315-assertio-holdings-scores-with-new-broadly-covered-asset Assertio Holdings Scores With New Broadly-Covered Asset Summary • Assertio Holdings, Inc. got the rights to Sympazan in October. • Most Medicare plans cover it. • Meanwhile, Assertio Holdings, Inc.'s lead product Indocin is a favored brand by the nation's #1 health insurance company. ...

https://www.globenewswire.com/news-release/2023/01/09/2585674/0/en/Assertio-Holdings-Inc-Announces-FDA-Orange-Book-Listing-for-New-Sympazan-Oral-Film-Patent.html